(Q73470997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

["Multiple sclerosis plus": leukoencephalopathies at the frontiers of internal medicine] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

J Pelletier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Ali Chérif

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1104-1113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

The pathology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Multiple sclerosis: therapeutic update

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

In healthy primates, circulating autoreactive T cells mediate autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Clinical and laboratory features of primary progressive and secondary progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Neurological complications in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Behçet's disease and the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Masked assessment of MRI findings: is it possible to differentiate neuro-Behçet's disease from other central nervous system diseases? [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Long-term MR follow-up of cerebral lesions in neuro-Behçet's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

MRI in 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

The place of Behçet's syndrome among the autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Systemic lupus erythematosus presenting with neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Transverse myelitis as a first manifestation of systemic lupus erythematosus: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Devic's syndrome and systemic lupus erythematosus: a case report with necropsy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

MS and SLE in twins of successive generations

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Central nervous system sarcoidosis--diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Sjögren's syndrome in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

The prevalence of primary Sjögren's syndrome in a multiple sclerosis population

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Primary Sjögren's syndrome in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

An association between multiple sclerosis and type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Multiple sclerosis and Hashimoto's thyroiditis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Diseases that mimic multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Multiple sclerosis and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Autoimmunity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Association of MS with thyroid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Multiple sclerosis and chronic inflammatory diseases. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Frequency of anti-nuclear antibodies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Antinuclear antibodies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Antinuclear antibodies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Frequency and significance of antinuclear antibodies in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Anticardiolipin antibodies in Japanese patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

No evidence for increased frequency of autoantibodies during interferon-beta1b treatment of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Autoimmune events during interferon beta-1b treatment for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Subacute thyroiditis in a patient with MS treated with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Severe Raynaud's phenomenon associated with interferon-beta treatment for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Subacute cutaneous lupus erythematosus associated with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2900270-8

7 January 2021

10.1016/S0248-8663(00)00270-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11191677%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference